By Marcia Dunn

NASA completed an engine test firing of its moon rocket Thursday, after the first attempt in January ended prematurely.

This time, the four main engines of the rocket’s core stage remained ignited for the full eight minutes. Applause broke out in the control room at Mississippi's Stennis Space Flight Center once the engines shut down on the test stand.

NASA officials called it a major milestone in sending astronauts back to the moon, but declined to say when that might occur or even whether the first test flight without a crew would occur by year's end as planned.

John Honeycutt, NASA's program manager for the Space Launch System or SLS rocket, said everything seemed to go well in Thursday's test firing. “The core stage ... got an A-plus today,” he told reporters.

During the first test, the engines fired for just a minute, automatically cut short by strict test limits that were relaxed for the redo. Valve issues also had to be resolved prior to Thursday's countdown.

With this critical test finally finished — and assuming everything went well — NASA can now send the rocket segment to Florida's Kennedy Space Center to prepare it for launch.

Noting they're taking it one step at a time, officials declined to say whether this first SLS launch will occur by year's end as had been planned or will bump into 2022. The SLS rocket will send an empty Orion capsule to the moon and back.

The four engines tested Thursday actually flew into orbit on NASA's space shuttles and were upgraded for the more powerful SLS system. The orange core stage is reminiscent of the shuttle's external fuel tank, which held the liquid hydrogen and oxygen that fed the main engines.

Boeing built the core stage, which stands 212 feet (65 meters.)

The Trump administration had pressed for a moon landing by astronauts by 2024, a deadline increasingly difficult if not impossible to achieve at this point. The current White House has yet to issue a revised timeline.

NASA Acting Administrator Steve Jurczyk said the space agency is conducting an internal study to determine a schedule for the astronaut moon landings — “what we can optimally do” based on budgets. The review will take a few months, he noted.

Share:
More In Science
As U.S. Opioid Crisis Worsens, Price of Life-Saving Drug Naloxone Skyrockets
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Legal Questions Swirl as States Push Back Against Biden COVID Vaccine Mandate
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
What COVID-19 Vaccines for Kids Might Mean for Fight Against Pandemic
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
Everything You Need to Know About Child Covid-19 Vaccines
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
Load More